Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Clinical Laboratory Achieves CLIA Certification

NEW YORK (GenomeWeb News) – Korean genomics services firm Macrogen said today that its Rockville, Md.-based subsidiary has received CLIA certification.

Macrogen Clinical Laboratory, launched in late 2012, offers diagnostic testing for genetic diseases through clinical whole-exome sequencing and targeted sequencing, and provides a "total genomic solution" for the clinical and research area, its Medical Director Sechin Cho said in a statement. He added that the company will expand its services to include DNA chip-based neo-genome scanning and cancer diagnostic panels, as well as transcriptome sequencing.

Macrogen is based in Seoul, South Korea and is equipped with 30 next-generation sequencers from Illumina, Roche, and Life Technologies' Ion Proton business, it said.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.